Court upholds $34M damages and ongoing royalties for Sight Sciences over Alcon patent infringement

Sight Sciences won a court ruling confirming Alcon's willful infringement of three patents related to the Hydrus Microstent. The court awarded Sight Sciences over $34 million in past damages plus ongoing royalties of 10% on Hydrus sales through November 2028. The final judgment is pending calculation of supplemental damages and interest and may be appealed by Alcon. This victory strengthens Sight Sciences' intellectual property position and supports continued innovation in glaucoma treatment technologies.